An observational study in Morality, Morbidity;Newborn and Very Preterm Maturity of Infant, sponsored by Nanjing Medical University. Completed at 1 site in China. Open to participants aged 1 Day to 28 Days. Per ClinicalTrials.gov, last updated 2022-03-03.
Sponsored by Nanjing Medical University · Observational
Care practices, mortality and morbidity of very premature infants from two different tertiary centers were collected and compared, in order to discover areas for improvement where these two newborn centers can learn from each other.
This retrospective cohort study was conducted in two hospitals,Qinghai Red Cross Hospital and Jinan University affiliated Shenzhen Baoan Women's and Children's Hospital.Very premature infants born with a gestational age between 22+0 - 31+6 weeks admitted to both centers during 3 years from January 1, 2018 to December 31, 2020 were studied. In both centers, data including maternal characteristics, neonatal characteristics, obstetric practices, delivery room practices, and neonatal outcomes, were collected by data abstractors in each NICU. Anonymous data was transferred to Shenzhen and analyses were performed at the newborn center of SZH.
2,554 studies on the registry are indexed under Premature Birth; 498 are open to participants now.
This study's enrollment of 807 is above the median of 112 across 777 observational studies indexed under Premature Birth.
Browse Premature Birth studies →Nanjing Medical University is the lead sponsor of 169 studies on the registry; 51 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Very premature infants born with a gestational age between 22+0 - 31+6 weeks admitted to newborn centers of Qinghai Red Cross Hospital and Shenzhen Baoan Women's and Children's Hospital from Jan 1, 2018 to Dec 31, 2020.
Exclusion Criteria:
mortality
death during hospitalisation and death after withdrawing treatment
Time frame: Jan 1,2018 - Dec 31,2020
Major morbidity
severe neurological injury, moderate to severe BPD, NEC or severe ROP
Time frame: Jan 1,2018 - Dec 31,2020
Plan to share: Undecided
No publications or documents are linked to this record.
This study is completed, as verified in Feb 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Nanjing Medical University